A large long-term study of nearly 355,000 adults found that coffee consumption was associated with lower risks of cirrhosis, liver cancer and liver-related death, although the research does not prove that coffee directly prevents disease.
Editorial Note
This article provides independent health reporting and general educational information. It does not provide medical advice or recommend that readers begin drinking coffee, increase their caffeine intake or use coffee to prevent or treat liver disease.
The study discussed below was observational. It found associations between coffee consumption and several liver-health outcomes, but it did not prove that coffee directly caused the lower risks.
New To Education is not affiliated with the researchers, Cedars-Sinai, the UK Biobank, the journal Clinical Gastroenterology and Hepatology, coffee manufacturers or healthcare providers discussed in this article.
A large long-term study has added new evidence to the idea that coffee may be associated with better liver health.
Researchers examined health information from nearly 355,000 adults and found that people who drank coffee generally experienced lower rates of cirrhosis, liver cancer and death related to liver disease than people who did not drink coffee.
Coffee drinkers also showed healthier patterns on liver scans and blood-protein testing, including lower measures connected to liver fat, inflammation, excess iron and tissue scarring.
The results are notable because the research did more than compare coffee habits with diagnosed disease. It also examined physical and molecular signs that may help explain why coffee has repeatedly been associated with healthier liver outcomes.
However, the findings should not be interpreted as proof that coffee prevents liver disease.
The research was observational, and the investigators did not randomly assign people to drink different amounts of coffee. Other lifestyle, health and behavioral differences may have contributed to the results.
The Study Followed Nearly 355,000 Adults
The research team analyzed data from 354,957 participants in the UK Biobank.
None of the participants had a known history of cirrhosis or liver cancer when the study began. Researchers then used linked health records to track new diagnoses of cirrhosis, liver cancer and liver-related deaths over a median follow-up period of approximately 13 years.
That combination of a large population and long follow-up period gave the researchers an opportunity to examine relatively uncommon but serious outcomes.
It also allowed them to compare reported coffee consumption with several different measures of liver health.
The study, titled “Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank,” was published in Clinical Gastroenterology and Hepatology. The findings were publicly highlighted by Cedars-Sinai on July 25, 2026.
Coffee Drinkers Had Lower Rates of Serious Liver Outcomes
Participants who reported drinking coffee generally experienced better liver outcomes than those who reported drinking none.
Among people consuming five or more cups per day, researchers reported a 32% lower risk of cirrhosis, a 47% lower risk of liver cancer and a 42% lower risk of dying from liver disease compared with non-coffee drinkers.
Those figures describe relative differences between groups. They do not mean that drinking coffee reduces every individual’s personal risk by those exact percentages.
The strongest associations appeared around three to four cups per day, although signs of potential benefit were also present among people consuming one or two cups.
Researchers specifically cautioned that the results should not be interpreted as advice to begin drinking five or more cups daily.
A high intake may not be appropriate for many people, and the observational design cannot determine an ideal dose for preventing disease.
Liver Scans Showed Less Fat, Inflammation and Scarring
One of the study’s more important features was its use of liver magnetic resonance imaging.
Researchers examined scans for signs of liver fat, excess iron, inflammation and fibrosis, which is the buildup of scar tissue.
People who consumed more coffee generally showed healthier measurements across those categories.
This matters because cirrhosis and liver cancer usually develop through a long process rather than appearing suddenly. Chronic inflammation, fat accumulation and fibrosis can gradually damage the liver before severe disease is diagnosed.
The imaging findings provide a possible connection between coffee consumption and the lower rates of serious liver outcomes observed later.
They do not establish that coffee caused the healthier scans, but they strengthen the biological plausibility of the association.
Blood Proteins Offered Additional Clues
The study also examined blood proteins associated with liver function, inflammation and tissue scarring.
People drinking more coffee had higher levels of some proteins connected with healthier liver function and lower levels of proteins associated with inflammation and fibrosis.
Proteomic testing allows researchers to examine patterns across many proteins rather than focusing on only one blood marker.
Those patterns may eventually help scientists identify which biological pathways are influenced by compounds found in coffee.
The researchers said future work will focus on determining which specific substances may be connected to the observed effects.
Coffee contains hundreds of naturally occurring compounds, including polyphenols and other chemicals that may influence inflammation, oxidative stress and metabolism.
The current study did not establish which compound—or combination of compounds—was responsible.
Decaffeinated Coffee Showed Similar Associations
Both caffeinated and decaffeinated coffee were associated with better liver outcomes.
That finding suggests caffeine alone may not explain the relationship.
It may also be relevant for people who enjoy coffee but limit caffeine because of sleep difficulties, anxiety, heart rhythm concerns or other health reasons.
However, the study does not prove that switching to decaffeinated coffee will improve liver health.
Preparation methods, serving sizes and additives such as sugar and cream may also differ considerably among coffee drinkers.
The available research focuses largely on coffee consumption as a broad behavior rather than every possible type of coffee drink.
A heavily sweetened specialty beverage may have a very different nutritional profile from plain brewed coffee.
The Study Does Not Prove Cause and Effect
The largest limitation is that the research was observational.
Researchers recorded patterns already present within a large population. They did not randomly assign participants to coffee or no-coffee groups and then control all other aspects of their lives.
Coffee drinkers may differ from non-coffee drinkers in ways that are difficult to measure completely.
They may have different diets, exercise habits, alcohol use, medication patterns, occupations, incomes or healthcare access.
Statistical adjustments can account for many known differences, but they cannot eliminate every possible source of bias.
The study therefore supports an association rather than a causal conclusion.
It would be inaccurate to say the research proved that coffee prevents cirrhosis or liver cancer.
Coffee Should Not Replace Established Liver-Health Practices
The researchers emphasized that coffee should complement—not replace—established approaches to liver health.
Maintaining a healthy weight, limiting alcohol, exercising regularly and managing blood sugar, blood pressure and cholesterol remain important.
Vaccination against hepatitis B, testing for hepatitis C when appropriate and following medical advice for existing liver conditions are also important preventive measures.
People at risk of metabolic dysfunction-associated steatotic liver disease may need individualized guidance involving nutrition, physical activity and treatment of related conditions such as diabetes or high cholesterol.
Someone with liver symptoms or abnormal blood tests should not attempt to manage the problem through coffee alone.
Liver disease often produces few symptoms during its earlier stages, which makes appropriate medical evaluation especially important.
More Coffee Is Not Automatically Better
The fact that the highest-consumption group showed lower relative risks does not mean everyone should increase their intake.
Caffeine can contribute to insomnia, anxiety, heart palpitations, digestive discomfort and increased blood pressure in some individuals.
Pregnant people are commonly advised to limit caffeine. People taking certain medications or managing heart rhythm disorders, uncontrolled high blood pressure or severe anxiety may also need restrictions.
Tolerance varies considerably.
One person may drink several cups without noticeable problems, while another may experience side effects after a small amount.
The study’s authors did not recommend that non-coffee drinkers begin using it specifically for liver protection.
How Much Coffee Did the Research Suggest?
The study found signs of healthier outcomes even among participants consuming one or two cups per day.
The strongest overall associations appeared at approximately three to four cups.
However, that does not establish a medically recommended intake.
Cup size can vary, and the caffeine content of coffee depends on the beans, brewing method and serving.
A small home-brewed cup and a large commercial drink may contain very different caffeine levels.
The research also relied on participants’ reported habits, which may change over time or contain some measurement error.
The most responsible interpretation is that moderate coffee consumption among people who already enjoy and tolerate it may fit within a healthy lifestyle.
The findings do not justify treating coffee as medication.
Why Liver Health Matters
The liver performs essential functions involving metabolism, digestion, toxin processing, immune activity and nutrient storage.
Chronic liver disease can develop from several causes, including viral hepatitis, heavy alcohol consumption, metabolic disease, autoimmune conditions and inherited disorders.
Cirrhosis occurs when long-term damage causes extensive scarring and interferes with normal liver function.
People with cirrhosis also face an increased risk of liver cancer.
Because early liver disease may not produce obvious symptoms, prevention and early detection are important.
The new coffee research is encouraging because it identifies a common dietary behavior associated with several measures of healthier liver function.
It should still be viewed as one part of a much larger prevention picture.
What Researchers Need to Study Next
The current findings raise several important questions.
Researchers need to identify which compounds in coffee may influence liver inflammation and fibrosis.
They also need to determine whether the associations differ according to age, sex, ethnicity, genetics, existing metabolic conditions or the cause of liver disease.
Randomized trials could provide stronger evidence, although long-term trials involving outcomes such as liver cancer would be difficult and expensive.
Shorter trials may instead examine changes in liver fat, inflammation, enzymes or other biomarkers.
Researchers may also investigate whether brewing methods matter.
Filtered, unfiltered, instant, espresso and cold-brew coffee contain different amounts of various compounds.
Understanding those differences could eventually lead to more specific guidance.
What Readers Should Take From the Findings
The research supports a growing body of evidence linking coffee with favorable liver outcomes.
Its size, long follow-up period, imaging data and protein analysis make it stronger than a simple dietary survey.
At the same time, the study does not prove that coffee directly prevents disease.
Readers should avoid turning a promising association into a guaranteed health claim.
People who already drink moderate amounts of coffee and tolerate it well may find the results reassuring.
People who do not drink coffee should not feel compelled to begin solely because of this study.
Personal decisions involving caffeine, liver disease or other health conditions should be discussed with a qualified healthcare professional.
How New To Education Covers Health Research
New To Education reports on emerging health findings to help readers understand what researchers discovered, what the evidence can support and what remains uncertain.
Health headlines often make observational findings sound like proven treatments.
Our goal is to separate the study’s actual results from claims that go beyond the available evidence.
Research can provide useful information without offering an immediate recommendation for every reader.
That distinction is especially important when a study involves familiar foods, supplements or daily habits that people can easily change without professional guidance.
Key Takeaways
A large observational study followed nearly 355,000 adults for a median of approximately 13 years.
Coffee consumption was associated with lower risks of cirrhosis, liver cancer and liver-related death.
People drinking more coffee also showed healthier liver imaging and blood-protein patterns involving fat, iron, inflammation and fibrosis.
Both caffeinated and decaffeinated coffee were associated with favorable outcomes, suggesting caffeine may not be the only relevant component.
Signs of benefit appeared among people drinking one or two cups, with the strongest associations around three to four cups daily.
The study does not prove coffee directly prevents liver disease because participants were not randomly assigned to different intake levels.
Researchers do not recommend that people begin drinking coffee or substantially increase their consumption solely for liver protection.
Frequently Asked Questions
Was this health research published today?
The public research announcement was released on July 25, 2026. It was the newest major health-research finding New To Education could verify as of July 26.
How many people were included in the study?
Researchers examined data from 354,957 UK Biobank participants.
Did coffee prevent liver cancer?
The study found that coffee drinkers had lower rates of liver cancer, but it did not prove that coffee directly prevented the disease.
Was decaffeinated coffee associated with benefits?
Yes. Both caffeinated and decaffeinated coffee were associated with more favorable liver outcomes.
Should people begin drinking more coffee?
Not based on this study alone. Coffee and caffeine are not appropriate for everyone, and the researchers did not recommend increasing intake specifically to prevent liver disease.
What are proven ways to support liver health?
Established approaches include limiting excessive alcohol, maintaining a healthy weight, exercising, managing metabolic conditions and receiving appropriate testing or vaccination for viral hepatitis.
Final Thoughts
The new study offers meaningful evidence that coffee consumption is associated with healthier liver outcomes.
Its findings extend beyond diagnosed disease. Liver scans and blood proteins also showed patterns consistent with less fat, inflammation and scarring among coffee drinkers.
That makes the research scientifically interesting.
It does not turn coffee into a treatment.
The study cannot prove that coffee caused the lower risks, and individual health decisions should not be based on one observational analysis.
The most balanced conclusion is that moderate coffee consumption may be compatible with liver health for people who already enjoy and tolerate it.
Future studies will need to identify the compounds involved, determine who may benefit and establish whether changing coffee intake produces measurable improvements.
Until then, coffee should be viewed as a possible contributor to a broader healthy lifestyle—not a substitute for medical care or established prevention.
Support New To Education
New To Education publishes independent reporting and analysis on health research, education, business, technology and public policy.
Readers can support our work by sharing this article, subscribing to our updates, following New To Education on social media or exploring the services available through our platform.
Related Articles
Coffee May Support Healthy Aging Through a Hidden Cellular Switch
https://www.newtoeducation.com/view-blog/coffee-may-support-healthy-aging-through-a-hidden-cellular-switch-6a5d871db657f
New Health Research from July 6, 2026: Cholesterol Testing, Exercise, Pregnancy Risks and Brain Health
https://www.newtoeducation.com/view-blog/new-health-research-from-july-6-2026-cholesterol-testing-exercise-pregnancy-risks-and-brain-health-6a4c64d98fd8f
Sources
Cedars-Sinai — Coffee May Help Shield the Liver From Fat, Scarring and Cancer
https://www.cedars-sinai.org/newsroom/coffee-may-help-shield-the-liver-from-fat-scarring-and-cancer/
Clinical Gastroenterology and Hepatology — Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank
https://doi.org/10.1016/j.cgh.2026.04.035
ScienceDaily — Coffee May Help Shield the Liver From Fat, Scarring and Cancer
https://www.sciencedaily.com/releases/2026/07/260719035955.htm
